摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-bis-(2'-hydroxy-4'-hexyloxy-benzoyl)-benzene | 30596-65-7

中文名称
——
中文别名
——
英文名称
1,3-bis-(2'-hydroxy-4'-hexyloxy-benzoyl)-benzene
英文别名
[3-(4-Hexoxy-2-hydroxybenzoyl)phenyl]-(4-hexoxy-2-hydroxyphenyl)methanone
1,3-bis-(2'-hydroxy-4'-hexyloxy-benzoyl)-benzene化学式
CAS
30596-65-7
化学式
C32H38O6
mdl
——
分子量
518.65
InChiKey
RLZQZZFNPPNTTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.6
  • 重原子数:
    38
  • 可旋转键数:
    16
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    93.1
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • Method for the preparation of aromatic chloroformates
    申请人:Davis Charles Gary
    公开号:US20060293535A1
    公开(公告)日:2006-12-28
    A method for preparing an aromatic chloroformate comprising, introducing a mixture of at least one aromatic hydroxyl compound, phosgene, at least one solvent, and at least one organic base into a flow reactor to obtain a unidirectionally flowing reaction mixture. The unidirectionally flowing reaction mixture is maintained at a temperature between about 0° C. and about 60° C. to produce a single product stream comprising an aromatic chloroformate.
    一种制备芳香氯甲酸酯的方法包括,将至少一种芳香羟基化合物、光气、至少一种溶剂和至少一种有机碱的混合物引入流动反应器中,以获得单向流动的反应混合物。将单向流动的反应混合物保持在约0°C至约60°C的温度下,以产生包含芳香氯甲酸酯的单一产物流。
  • Method for the preparation of aliphatic chloroformates
    申请人:Davis Charles Gary
    公开号:US20060084822A1
    公开(公告)日:2006-04-20
    A method for preparing an aliphatic chloroformate comprising, introducing a mixture of at least one aliphatic hydroxyl compound, phosgene, at least one solvent, and optionally at least one organic base into a flow reactor to obtain a unidirectional flowing reaction mixture. The at least one aliphatic hydroxyl compound comprises at least one aliphatic hydroxyl group. The unidirectional flowing reaction mixture is maintained at a temperature between about 0° C. and about 60° C. to produce a single product stream comprising an aliphatic chloroformate.
    制备脂肪基氯甲酸酯的方法包括,将至少一种脂肪基羟基化合物、光气、至少一种溶剂以及可选的至少一种有机碱的混合物引入流动反应器中,以获得单向流动的反应混合物。至少一种脂肪基羟基化合物包括至少一种脂肪基羟基。将单向流动的反应混合物保持在约0°C至约60°C的温度下,以产生包含脂肪基氯甲酸酯的单一产物流。
  • FLUORESCENT BRIGHTENERS, METHODS OF PREPARATION THEREOF, FLUORESCENT BRIGHTENER COMPOSITIONS, AND METHODS OF PREPARATION AND USES THEREOF
    申请人:Naik Shantaram Narayan
    公开号:US20110065843A1
    公开(公告)日:2011-03-17
    A compound of Formula (I) wherein R 1 , R 2 , and R 3 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality, with the proviso that R 2 and R 3 are not hydrogen when R 1 is a methyl or hydrogen; R 4 and R 5 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 7 and R 8 are independently at each occurrence, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 6 is a C 2 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality; and “n” and “m” are each independently integers having a value of 0 to 3.
    化合物的化学式(I),其中R1、R2和R3在每次出现时独立地为氢、卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基,但R1为甲基或氢时,R2和R3不为氢;R4和R5在每次出现时独立地为氢、卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基;R7和R8在每次出现时独立地为卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基;R6为C2-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基;“n”和“m”分别独立地为0至3的整数。
  • Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
    申请人:Naik Narayan Shantaram
    公开号:US20070117887A1
    公开(公告)日:2007-05-24
    A compound of Formula (I) wherein R 1 , R 2 , and R 3 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality, with the proviso that R 2 and R 3 are not hydrogen when R 1 is a methyl or hydrogen; R 4 and R 5 are independently at each occurrence hydrogen, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 7 and R 8 are independently at each occurrence, a halogen, a cyano functionality, a C 1 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 10 aromatic functionality; R 6 is a C 2 -C 20 aliphatic functionality, a C 3 -C 10 cycloaliphatic functionality or a C 3 -C 20 aromatic functionality; and “n” and “m” are each independently integers having a value of 0 to 3.
    式(I)的化合物,其中R1、R2和R3在每次出现时独立地为氢、卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基,但R1为甲基或氢时,R2和R3不为氢;R4和R5在每次出现时独立地为氢、卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基;R7和R8在每次出现时独立地为卤素、基、C1-C20脂肪基、C3-C10环脂肪基或C3-C10芳香基;R6为C2-C20脂肪基、C3-C10环脂肪基或C3-C20芳香基;“n”和“m”分别独立地为0至3的整数。
  • Polycyclic dihydroxy compound and methods for preparation
    申请人:Raj Tilak T.
    公开号:US20070123713A1
    公开(公告)日:2007-05-31
    A process of forming a polycyclic dihydroxy compound is described. The polycyclic dihydroxy compound has Formula (I) wherein R 1 , R 2 and R 3 are independently at each occurrence selected from the group consisting of a cyano functionality, a halogen, an aliphatic functionality having 1 to 10 carbons, a cycloaliphatic functionality having 3 to 10 carbons, and an aromatic functionality having 6 to 10 carbons; and wherein each occurrence of “n”, “m”, and “p” independently has a value of 0, 1, 2, 3, or 4. Also described are polycyclic dihydroxy compounds of Formula (I) in which the phthalimide group is meta to the triaryl-substituted carbon.
    描述了一种形成多环二羟基化合物的过程。该多环二羟基化合物的化学式为(I),其中R1、R2和R3在每次出现时独立地选择自基、卤素、具有1至10个碳原子的脂肪基、具有3至10个碳原子的环脂肪基和具有6至10个碳原子的芳香基的群组中的一种功能基;且“n”、“m”和“p”的每次出现独立地具有0、1、2、3或4的值。还描述了化学式(I)中邻苯二甲酰亚胺基团位于三芳基取代碳的情况下的多环二羟基化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫